Personal information

No personal information available

Activities

Collapse all

Education and qualifications (3)

University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences: Houston, TX, US

2016-07-22 to present | PhD Student (Genetics)
Education
Source: Self-asserted source
Darlan Conterno Minussi

Federal University of Rio Grande do Sul: Porto Alegre, RS, BR

2013-08-01 to 2015-08-13 | Master in Science (Programa de Pós Graduação em Biologia Celular e Molecular)
Education
Source: Self-asserted source
Darlan Conterno Minussi

Federal University of Health Sciences of Porto Alegre: Porto Alegre, RS, BR

2009-02-01 to 2013-06-15 | Bachelor in Biomedicine
Education
Source: Self-asserted source
Darlan Conterno Minussi

Works (9)

Breast tumours maintain a reservoir of subclonal diversity during expansion.

Nature
2021-03-24 | Journal article
DOI: 10.1038/s41586-021-03357-x
PMID: 33762732
Source: Self-asserted source
Darlan Conterno Minussi

MEDALT: single-cell copy number lineage tracing enabling gene discovery.

Genome biology
2021-02-23 | Journal article
DOI: 10.1186/s13059-021-02291-5
PMID: 33622385
PMC: PMC7901082
Source: Self-asserted source
Darlan Conterno Minussi

esiCancer: Evolutionary In Silico Cancer Simulator

Cancer Research
2019-03-01 | Journal article
DOI: 10.1158/0008-5472.can-17-3924
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Darlan Conterno Minussi

Systematic Functional Annotation of Somatic Mutations in Cancer

Cancer Cell
2018-03 | Journal article
DOI: 10.1016/j.ccell.2018.01.021
Part of ISSN: 1535-6108
Source: Self-asserted source
Darlan Conterno Minussi

Analysis of NTPDase2 in the cell membrane using fluorescence recovery after photobleaching (FRAP)

Cytometry Part A
2018-02 | Journal article
DOI: 10.1002/cyto.a.23317
Part of ISSN: 1552-4922
Source: Self-asserted source
Darlan Conterno Minussi

Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells

Neuro-Oncology
2016-04 | Journal article
DOI: 10.1093/neuonc/now062
Contributors: Pítia F. Ledur; Chong Liu; Hua He; Alexandra R. Harris; Darlan C. Minussi; Hai-Yan Zhou; Mark E. Shaffrey; Ashok Asthagiri; Maria Beatriz S. Lopes; David Schiff et al.
Source: Self-asserted source
Darlan Conterno Minussi via Crossref Metadata Search

A20 Expressing Tumors and Anticancer Drug Resistance

The Multiple Therapeutic Targets of A20
2014 | Other
DOI: 10.1007/978-1-4939-0398-6_5
Contributors: Cleide Gonçalves da Silva; Darlan Conterno Minussi; Christiane Ferran; Markus Bredel
Source: Self-asserted source
Darlan Conterno Minussi via Crossref Metadata Search

A20 Regulates Atherogenic Interferon (IFN)-  Signaling in Vascular Cells by Modulating Basal IFN  Levels

Journal of Biological Chemistry
2014-09 | Journal article
DOI: 10.1074/jbc.m114.591966
Contributors: H. P. Moll; A. Lee; D. C. Minussi; C. G. da Silva; E. Csizmadia; M. Bhasin; C. Ferran
Source: Self-asserted source
Darlan Conterno Minussi via Crossref Metadata Search

A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals

Hepatology
2013-04-05 | Journal article
DOI: 10.1002/hep.26197
Contributors: Cleide G. da Silva; Peter Studer; Marco Skroch; Jerome Mahiou; Darlan C. Minussi; Clayton R. Peterson; Suzhuei W. Wilson; Virendra I. Patel; Averil Ma; Eva Csizmadia et al.
Source: Self-asserted source
Darlan Conterno Minussi via Crossref Metadata Search
How many people are using ORCID?